Efficacy and Safety of Inclisiran According to Age: A Pooled Analysis of Phase III Studies (ORION 9, 10 and 11)

Heart, Lung and Circulation（2023）

引用 0|浏览10

暂无评分

摘要

To assess the efficacy and safety of inclisiran across age categories <65 years (not old), ≥65 and <75 years (old), or ≥75 years (very old).

查看译文

关键词

inclisiran,efficacy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要